What’s New at the Network
Severe Asthma Study Insight
Medical Advisor Vickram Tejwani, MD, and Asthma Coach Leandra Tonweber, PA-C, AE-C, offered their perspective on an eosinophilic asthma study examining the reduced use of inhaled corticosteroids (ICS) among people taking the biologic benralizumab. Dr. Tejwani told Healio.com the findings were “significant” and offer data to support reducing ICS in people who respond well to biologic therapy.
Support for New EPIPEN Act
Allergy & Asthma Network is among patient advocacy groups supporting the EPIPEN Act introduced in Congress by Rep. Maxwell Frost (FL). The legislation would put a price cap on epinephrine auto-injectors. “High out-of-pocket costs for these potentially life-saving medications put Americans with severe allergies at risk for poor health outcomes and deepen health inequities,” CEO Lynda Mitchell says.
Newly Updated Poster for 2024
Our popular Respiratory Treatments poster is newly updated for 2024 – and available now! It contains the newest asthma and COPD medications, including AirSupra®. The poster offers a comparison of the various treatment options, helps doctors and patients easily identify inhalers, and is a great reference for patient education. It’s available in both English and Spanish.
Allergy & Asthma In the News
Learn about a current research study looking into the use of a biologic, omalizumab to determine if it can aid food allergy oral immunotherapy (OIT).
A new medication supports treating asthma symptoms and inflamed airways in the short and long term using one inhaler device.
Migraine is a very common neurological disease. It involves moderate to severe throbbing and...
See More News Articles
Advancing Nationwide Efforts to Engage, Educate & Empower
At Allergy & Asthma Network, we are here to serve and support you. We work with national and local partners to train healthcare professionals and host events and screenings that reach people directly in their communities. We raise awareness and educate millions each year with easy-to-understand, medically reviewed resources in English and Spanish. We advocate at the federal and state levels to improve access to care and affordable medications. We work to ensure the patient voice is included in research and drug development.
Your health and well-being are at the heart of our work. Our goal is to improve quality of life and achieve equitable and optimal health outcomes for adults and children living with these chronic conditions, especially those in underserved communities.
Check out our Events Calendar for Webinars, Trusted Messengers Events, and other Allergy & Asthma Network supported events.
Recent & Upcoming Webinars
Free Webinar May 2, 2024 at 12 PM ET — Approximately 20 million Americans have food allergies learn about the current approaches of food allergy management.
Free Webinar March 21, 2024 at 12 PM ET – learn about how insect allergies are diagnosed and treated and how to be prepared for a potential allergic reaction.
Join us for a free webinar: March 14th at 12 PM ET – Learn about ways that seasonal allergies may trigger asthma symptoms and how you can manage it.
In a special episode of our podcast series, ACAAI President Gailen Marshall, MD discusses what ACAAI does and why the organization matters to patients.
In this new podcast, Kortney Kwong Hing and Dr. Payel Gupta are joined by Anne Maitland, MD, to discuss symptoms and triggers of mast cell disease.
In this episode of the “Allergy, Asthma & Immunology Innovations” podcast series, we...
See More Podcasts